Cladribine is a safe and effective treatment for highly active relapsing-remitting multiple sclerosis

被引:0
|
作者
Suslak, T. [1 ]
Macdougall, N. [2 ]
Murray, L. [1 ]
机构
[1] NHSGGC, Glasgow, Lanark, Scotland
[2] NHSGGC, NHSL, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P0309
引用
收藏
页码:269 / 269
页数:1
相关论文
共 50 条
  • [21] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [22] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [23] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [24] Considerations in the treatment of relapsing-remitting multiple sclerosis
    Calabresi, PA
    NEUROLOGY, 2002, 58 (08) : S10 - S22
  • [25] Ponesimod for the treatment of relapsing-remitting multiple sclerosis
    Gaber, Tarek A-Z K.
    Eltemamy, Marwa
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2022, 26 (02) : 18 - 19
  • [26] Efficacy and safety of natalizumab in children with highly active relapsing-remitting multiple sclerosis
    Karageorgiou, Klimentini E.
    Polyzoi, Maria
    Tzitzika, Moira
    Xatzi, Ioanna
    Alexoudi, Athanasia
    MULTIPLE SCLEROSIS, 2008, 14 : S51 - S51
  • [27] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [28] Longitudinally Extensive Transverse Myelitis in Highly Active Relapsing-remitting Multiple Sclerosis
    Ng, Chen Fei
    Remli, Rabani
    Tan, Hui Jan
    NEUROLOGY INDIA, 2021, 69 (05) : 1412 - 1413
  • [29] Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
    Murphy, Julie A.
    Harris, Jacklyn A.
    Crannage, Andrew J.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 619 - 625
  • [30] BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S205 - S205